Perturbed myelination process of premyelinating oligodendrocyte in Niemann-Pick type C mouse

Journal of Neuropathology and Experimental Neurology

Volumn 63, Issue 6, 2004, Pages 660-673

  Takikita, Shoichi ^a   Fukuda, Takahiro ^a   Mohri, Ikuko ^a   Yagi, Takashi ^a   Suzuki, Kinuko ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Axon glial interaction; Hypomyelination; Niemann Pick disease type C; Oligodendrocyte progenitor cells; Polysialylated neural cell adhesion molecule; Premyelinating oligodendrocyte

Indexed keywords

GLUTATHIONE TRANSFERASE; MYELIN BASIC PROTEIN; NERVE CELL ADHESION MOLECULE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BRAIN CORTEX; CELL INTERACTION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CORPUS CALLOSUM; FEMALE; GENE; GENE FUNCTION; GLIA; IMMUNOHISTOCHEMISTRY; LIPIDOSIS; MALE; MOUSE; MOUSE MUTANT; MYELINATION; NERVE CELL DIFFERENTIATION; NERVE FIBER; NIEMANN PICK DISEASE; NONHUMAN; NPC1 GENE; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; SIALYLATION; SIGNAL TRANSDUCTION; STEM CELL; WHITE MATTER;

EID: 2942624018     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/63.6.660     Document Type: Article

References (49)

1. Millat G, Marcais C, Tomasetto C, et al. Niemann-Pick C1 disease: Correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop. Am J Hum Genet 2001;68:1373-85
2. Millat G, Marcais C, Rafi MA, et al. Niemann-Pick C1 disease: The I1061T substitution is a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype. Am J Hum Genet 1999;65:1321-29
3. Vanier MT, Duthel S, Rodriguez-Lafrasse C, Pentchev P, Carstea ED. Genetic heterogeneity in Niemann-Pick C disease: A study using somatic cell hybridization and linkage analysis. Am J Hum Genet 1996;58:118-25
4. Vanier MT, Millat G. Niemann-Pick disease type C. Clin Genet 2003;64:269-81
5. Higashi Y, Murayama S, Pentchev P, Suzuki K. Pathology of Niemann-Pick type C: Studies of murine mutant. In: Ikuta F, ed. Neuropathology in brain research. Amsterdam: Elsevier, 1991:85-102
6. Loftus SK, Morris JA, Carstea ED, et al. Murine model of Niemann-Pick C disease: Mutation in a cholesterol homeostasis gene. Science 1997;277:232-35
7. Morris MD, Bhuvaneswaran C, Shio H, Fowler S. Lysosome lipid storage disorder in NCTR-BALB/c mice. I. Description of the disease and genetics. Am J Pathol 1982;108:140-49
8. Weintraub H, Abramovici A, Sandbank U, et al. Neurological mutation characterized by dysmyelination in NCTR-Balb/C mouse with lysosomal lipid storage disease. J Neurochem 1985;45:665-72
9. Weintraub H, Abramovici A, Sandbank U, Booth AD, Pentchev PG, Sela B. Dysmyelination in NCTR-Balb/C mouse mutant with a lysosomal storage disorder. Morphological survey. Acta Neuropathol (Berl) 1987;74:374-81
10. Baracskay KL, Duchala CS, Miller RH, Macklin WB, Trapp BD. Oligodendrogenesis is differentially regulated in gray and white matter of jimpy mice. J Neurosci Res 2002;70:645-54
11. Seiwa C, Kojima-Aikawa K, Matsumoto I, Asou H. CNS myelinogenesis in vitro: Myelin basic protein deficient shiverer oligodendrocytes. J Neurosci Res 2002;69:305-17
12. Barres BA, Raff MC. Axonal control of oligodendrocyte development. J Cell Biol 1999;147:1123-28
13. Barres BA, Raff MC. Proliferation of oligodendrocyte precursor cells depends on electrical activity in axons. Nature 1993;361:258-60
14. Givogri MI, Costa RM, Schonmann V, Silva AJ, Campagnoni AT, Bongarzone ER. Central nervous system myelination in mice with deficient expression of Notch1 receptor. J Neurosci Res 2002;67:309-20
15. Wang S, Sdrulla AD, diSibio G, et al. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 1998;21:63-75
16. Charles P, Hernandez MP, Stankoff B, et al. Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule. Proc Natl Acad Sci USA 2000;97:7585-90
17. Charles P, Reynolds R, Seilhean D, et al. Re-expression of PSA-NCAM by demyelinated axons: An inhibitor of remyelination in multiple sclerosis? Brain 2002;125:1972-79
18. Patel SC, Suresh S, Kumar U, et al. Localization of Niemann-Pick C1 protein in astrocytes: Implications for neuronal degeneration in Niemann-Pick type C disease. Proc Natl Acad Sci USA 1999;96:1657-62
19. Ong WY, Kumar U, Switzer RC, et al. Neurodegeneration in Niemann-Pick type C disease mice. Exp Brain Res 2001;141:218-31
20. Suzuki H, Sakiyama T, Harada N, Abe M, Tadokoro M. Pathologic changes of glial cells in murine model of Niemann-Pick disease type C: Immunohistochemical, lectin-histochemical and ultrastructural observations. Pediatr Int 2003;45:1-4
21. McLean IW, Nakane PK. Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy. J Histochem Cytochem 1974;22:1077-83
22. Taniike M, Mohri I, Eguchi N, et al. An apoptotic depletion of oligodendrocytes in the twitcher, a murine model of globoid cell leukodystrophy. J Neuropathol Exp Neurol 1999;58:644-53
23. Uehara H, Yoshioka H, Kawase S, et al. A new model of white matter injury in neonatal rats with bilateral carotid artery occlusion. Brain Res 1999;837:213-20
24. Trapp BD, Nishiyama A, Cheng D, Macklin W. Differentiation and death of premyelinating oligodendrocytes in developing rodent brain. J Cell Biol 1997;137:459-68
25. Scherer SS, Braun PE, Grinspan J, Collarini E, Wang DY, Kamholz J. Differential regulation of the 2′, 3′-cyclic nucleotide 3′-phosphodiesterase gene during oligodendrocyte development. Neuron 1994;12:1363-75
26. Reynolds R, Hardy R. Oligodendroglial progenitors labeled with the O4 antibody persist in the adult rat cerebral cortex in vivo. J Neurosci Res 1997;47:455-70
27. De Vellis J, Carpenter E. Development. In: Siegel J, ed. Basic neurochemistry: Molecular, cellular and medical aspects, 6th Ed. Philadelphia: Lippincott-Raven Publishers, 1999:537-63
28. Levine JM, Enquist LW, Card JP. Reactions of oligodendrocyte precursor cells to alpha herpesvirus infection of the central nervous system. Glia 1998;23:316-28
29. Nishiyama A, Yu M, Drazba JA, Tuohy VK. Normal and reactive NG2+ glial cells are distinct from resting and activated microglia. J Neurosci Res 1997;48:299-312
30. Jones LL, Yamaguchi Y, Stallcup WB, Tuszynski MH. NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J Neurosci 2002;22:2792-803
31. Bu J, Akhtar N, Nishiyama A. Transient expression of the NG2 proteoglycan by a subpopulation of activated macrophages in an excitotoxic hippocampal lesion. Glia 2001;34:296-310
32. Ciallella JR, Ikonomovic MD, Paljug WR, et al. Changes in expression of amyloid precursor protein and interleukin-1beta after experimental traumatic brain injury in rats. J Neurotrauma 2002;19:1555-67
33. Stangel M, Hartung HP. Remyelinating strategies for the treatment of multiple sclerosis. Prog Neurobiol 2002;68:361-76
34. Karten B, Vance DE, Campenot RB, Vance JE. Cholesterol accumulates in cell bodies, but is decreased in distal axons, of Niemann-Pick C1-deficient neurons. J Neurochem 2002;83:1154-63
35. Karten B, Vance DE, Campenot RB, Vance JE. Trafficking of cholesterol from cell bodies to distal axons in Niemann Pick C1-deficient neurons. J Biol Chem 2003;278:4168-75
36. Fan QW, Yu W, Senda T, Yanagisawa K, Michikawa M. Cholesterol-dependent modulation of tau phosphorylation in cultured neurons. J Neurochem 2001;76:391-400
37. Davies JP, Ioannou YA. Topological analysis of Niemann-Pick C1 protein reveals that the membrane orientation of the putative sterol-sensing domain is identical to those of 3-hydroxy-3-methylglutaryl-CoA reductase and sterol regulatory element binding protein cleavage-activating protein. J Biol Chem 2000;275:24367-74
38. Suzuki K, De Paul LD. Cellular degeneration in developing central nervous system of rats produced by hypocholesteremic drug AY9944. Lab Invest 1971;25:546-55
39. Suzuki K, Zagoren JC. Degeneration of oligodendroglia in the central nervous system of rats treated with AY9944 or triparanol. Lab Invest 1974;31:503-15
40. Salzer JL. Polarized domains of myelinated axons. Neuron 2003;40:297-318
41. Mathis C, Denisenko-Nehrbass N, Girault JA, Borrelli E. Essential role of oligodendrocytes in the formation and maintenance of central nervous system nodal regions. Development 2001;128:4881-90
42. Chang A, Tourtellotte WW, Rudick R, Trapp BD. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 2002;346:165-73
43. Gehrmann J, Banati RB, Cuzner ML, Kreutzberg GW, Newcombe J. Amyloid precursor protein (APP) expression in multiple sclerosis lesions. Glia 1995;15:141-51
44. Bruck W, Stadelmann C. Inflammation and degeneration in multiple sclerosis. Neurol Sci 2003;24(Suppl 5):S265-67
45. Seki T, Arai Y. Distribution and possible roles of the highly polysialylated neural cell adhesion molecule (NCAM-H) in the developing and adult central nervous system. Neurosci Res 1993;17:265-90
46. Genoud S, Lappe-Siefke C, Goebbels S, et al. Notch1 control of oligodendrocyte differentiation in the spinal cord. J Cell Biol 2002;158:709-18
47. Hu QD, Ang BT, Karsak M, et al. F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation. Cell 2003;115:163-75
48. Chun SJ, Rasband MN, Sidman RL, Habib AA, Vartanian T. Integrin-linked kinase is required for laminin-2-induced oligodendrocyte cell spreading and CNS myelination. J Cell Biol 2003;163:397-408
49. Park SK, Miller R, Krane I, Vartanian T. The erbB2 gene is required for the development of terminally differentiated spinal cord oligodendrocytes. J Cell Biol 2001;154:1245-58